Evaluation of estrogen and G protein-coupled estrogen receptor 1 (GPER) levels in drug-naïve patients with attention deficit hyperactivity disorder (ADHD).
Identifieur interne : 000931 ( PubMed/Curation ); précédent : 000930; suivant : 000932Evaluation of estrogen and G protein-coupled estrogen receptor 1 (GPER) levels in drug-naïve patients with attention deficit hyperactivity disorder (ADHD).
Auteurs : Nilfer Sahin [Turquie] ; Hatice Altun ; Ergül Belge Kuruta ; Ebru F Nd KlSource :
- Bosnian journal of basic medical sciences [ 1840-4812 ] ; 2018.
Descripteurs français
- KwdFr :
- MESH :
English descriptors
- KwdEn :
- MESH :
Abstract
Estrogen has a crucial role in the regulation of reproductive and neuroendocrine function and exerts its effects through two classes of receptors, nuclear and membrane estrogen receptors (mERs). G protein-coupled estrogen receptor 1 (GPER) is a member of mERs, and despite limited research on the levels of GPER in patients with psychiatric diseases, a role of GPER in such conditions has been suggested. Here we evaluated serum estrogen and GPER levels in children with attention deficit hyperactivity disorder (ADHD) in relation to their age- and gender-matched healthy controls. A total of 82 children were included in the study, 47 drug- naïve patients with ADHD (age: 6-12 years; male/female: 34/13) and 35 healthy controls (age: 6-12 years; male/female: 19/16). The subgroups according to ADHD types were inattentive, hyperactive/impulsive, and combined. Serum estrogen was measured using an immunoassay system, while serum GPER was determined using a commercial sandwich enzyme-linked immunosorbent assay kit. Estrogen levels in children with ADHD were similar as in control group, while GPER levels were significantly lower in ADHD group compared to controls (p < 0.05). Logistic regression analysis showed a significant association between GPER levels and ADHD (p < 0.05), and no association between estrogen levels and ADHD (p > 0.05). No significant differences were found in GPER and estrogen levels between ADHD subgroups (p > 0.05). To the best of our knowledge, this study is the first to investigate estrogen and GPER levels in ADHD. Our preliminary findings suggest a relationship between serum GPER levels and ADHD, and this should be further investigated.
DOI: 10.17305/bjbms.2018.2942
PubMed: 29659348
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000931
Links to Exploration step
pubmed:29659348Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Evaluation of estrogen and G protein-coupled estrogen receptor 1 (GPER) levels in drug-naïve patients with attention deficit hyperactivity disorder (ADHD).</title><author><name sortKey="Sahin, Nilfer" sort="Sahin, Nilfer" uniqKey="Sahin N" first="Nilfer" last="Sahin">Nilfer Sahin</name><affiliation wicri:level="1"><nlm:affiliation>Department of Child and Adolescent Psychiatry, School of Medicine, Mugla Sitki Kocman University, Mugla, Turkey. nilfersahin@hotmail.com.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>Department of Child and Adolescent Psychiatry, School of Medicine, Mugla Sitki Kocman University, Mugla</wicri:regionArea></affiliation></author><author><name sortKey="Altun, Hatice" sort="Altun, Hatice" uniqKey="Altun H" first="Hatice" last="Altun">Hatice Altun</name></author><author><name sortKey="Kuruta, Ergul Belge" sort="Kuruta, Ergul Belge" uniqKey="Kuruta E" first="Ergül Belge" last="Kuruta">Ergül Belge Kuruta</name></author><author><name sortKey="F Nd Kl, Ebru" sort="F Nd Kl, Ebru" uniqKey="F Nd Kl E" first="Ebru" last="F Nd Kl">Ebru F Nd Kl</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2018">2018</date><idno type="RBID">pubmed:29659348</idno><idno type="pmid">29659348</idno><idno type="doi">10.17305/bjbms.2018.2942</idno><idno type="wicri:Area/PubMed/Corpus">000931</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000931</idno><idno type="wicri:Area/PubMed/Curation">000931</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000931</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Evaluation of estrogen and G protein-coupled estrogen receptor 1 (GPER) levels in drug-naïve patients with attention deficit hyperactivity disorder (ADHD).</title><author><name sortKey="Sahin, Nilfer" sort="Sahin, Nilfer" uniqKey="Sahin N" first="Nilfer" last="Sahin">Nilfer Sahin</name><affiliation wicri:level="1"><nlm:affiliation>Department of Child and Adolescent Psychiatry, School of Medicine, Mugla Sitki Kocman University, Mugla, Turkey. nilfersahin@hotmail.com.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>Department of Child and Adolescent Psychiatry, School of Medicine, Mugla Sitki Kocman University, Mugla</wicri:regionArea></affiliation></author><author><name sortKey="Altun, Hatice" sort="Altun, Hatice" uniqKey="Altun H" first="Hatice" last="Altun">Hatice Altun</name></author><author><name sortKey="Kuruta, Ergul Belge" sort="Kuruta, Ergul Belge" uniqKey="Kuruta E" first="Ergül Belge" last="Kuruta">Ergül Belge Kuruta</name></author><author><name sortKey="F Nd Kl, Ebru" sort="F Nd Kl, Ebru" uniqKey="F Nd Kl E" first="Ebru" last="F Nd Kl">Ebru F Nd Kl</name></author></analytic><series><title level="j">Bosnian journal of basic medical sciences</title><idno type="eISSN">1840-4812</idno><imprint><date when="2018" type="published">2018</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Attention Deficit Disorder with Hyperactivity (blood)</term><term>Case-Control Studies</term><term>Child</term><term>Enzyme-Linked Immunosorbent Assay</term><term>Estradiol (blood)</term><term>Estrogens (blood)</term><term>Female</term><term>Humans</term><term>Male</term><term>Receptors, Estrogen (blood)</term><term>Receptors, G-Protein-Coupled (blood)</term><term>Regression Analysis</term><term>Sex Factors</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Analyse de régression</term><term>Enfant</term><term>Facteurs sexuels</term><term>Femelle</term><term>Humains</term><term>Mâle</term><term>Oestradiol (sang)</term><term>Oestrogènes (sang)</term><term>Récepteurs couplés aux protéines G (sang)</term><term>Récepteurs des oestrogènes (sang)</term><term>Test ELISA</term><term>Trouble déficitaire de l'attention avec hyperactivité (sang)</term><term>Études cas-témoins</term></keywords><keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Estradiol</term><term>Estrogens</term><term>Receptors, Estrogen</term><term>Receptors, G-Protein-Coupled</term></keywords><keywords scheme="MESH" qualifier="blood" xml:lang="en"><term>Attention Deficit Disorder with Hyperactivity</term></keywords><keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Oestradiol</term><term>Oestrogènes</term><term>Récepteurs couplés aux protéines G</term><term>Récepteurs des oestrogènes</term><term>Trouble déficitaire de l'attention avec hyperactivité</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Case-Control Studies</term><term>Child</term><term>Enzyme-Linked Immunosorbent Assay</term><term>Female</term><term>Humans</term><term>Male</term><term>Regression Analysis</term><term>Sex Factors</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Analyse de régression</term><term>Enfant</term><term>Facteurs sexuels</term><term>Femelle</term><term>Humains</term><term>Mâle</term><term>Test ELISA</term><term>Études cas-témoins</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Estrogen has a crucial role in the regulation of reproductive and neuroendocrine function and exerts its effects through two classes of receptors, nuclear and membrane estrogen receptors (mERs). G protein-coupled estrogen receptor 1 (GPER) is a member of mERs, and despite limited research on the levels of GPER in patients with psychiatric diseases, a role of GPER in such conditions has been suggested. Here we evaluated serum estrogen and GPER levels in children with attention deficit hyperactivity disorder (ADHD) in relation to their age- and gender-matched healthy controls. A total of 82 children were included in the study, 47 drug- naïve patients with ADHD (age: 6-12 years; male/female: 34/13) and 35 healthy controls (age: 6-12 years; male/female: 19/16). The subgroups according to ADHD types were inattentive, hyperactive/impulsive, and combined. Serum estrogen was measured using an immunoassay system, while serum GPER was determined using a commercial sandwich enzyme-linked immunosorbent assay kit. Estrogen levels in children with ADHD were similar as in control group, while GPER levels were significantly lower in ADHD group compared to controls (p < 0.05). Logistic regression analysis showed a significant association between GPER levels and ADHD (p < 0.05), and no association between estrogen levels and ADHD (p > 0.05). No significant differences were found in GPER and estrogen levels between ADHD subgroups (p > 0.05). To the best of our knowledge, this study is the first to investigate estrogen and GPER levels in ADHD. Our preliminary findings suggest a relationship between serum GPER levels and ADHD, and this should be further investigated.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29659348</PMID><DateCompleted><Year>2018</Year><Month>11</Month><Day>27</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1840-4812</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>2</Issue><PubDate><Year>2018</Year><Month>May</Month><Day>20</Day></PubDate></JournalIssue><Title>Bosnian journal of basic medical sciences</Title><ISOAbbreviation>Bosn J Basic Med Sci</ISOAbbreviation></Journal><ArticleTitle>Evaluation of estrogen and G protein-coupled estrogen receptor 1 (GPER) levels in drug-naïve patients with attention deficit hyperactivity disorder (ADHD).</ArticleTitle><Pagination><MedlinePgn>126-131</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.17305/bjbms.2018.2942</ELocationID><Abstract><AbstractText>Estrogen has a crucial role in the regulation of reproductive and neuroendocrine function and exerts its effects through two classes of receptors, nuclear and membrane estrogen receptors (mERs). G protein-coupled estrogen receptor 1 (GPER) is a member of mERs, and despite limited research on the levels of GPER in patients with psychiatric diseases, a role of GPER in such conditions has been suggested. Here we evaluated serum estrogen and GPER levels in children with attention deficit hyperactivity disorder (ADHD) in relation to their age- and gender-matched healthy controls. A total of 82 children were included in the study, 47 drug- naïve patients with ADHD (age: 6-12 years; male/female: 34/13) and 35 healthy controls (age: 6-12 years; male/female: 19/16). The subgroups according to ADHD types were inattentive, hyperactive/impulsive, and combined. Serum estrogen was measured using an immunoassay system, while serum GPER was determined using a commercial sandwich enzyme-linked immunosorbent assay kit. Estrogen levels in children with ADHD were similar as in control group, while GPER levels were significantly lower in ADHD group compared to controls (p < 0.05). Logistic regression analysis showed a significant association between GPER levels and ADHD (p < 0.05), and no association between estrogen levels and ADHD (p > 0.05). No significant differences were found in GPER and estrogen levels between ADHD subgroups (p > 0.05). To the best of our knowledge, this study is the first to investigate estrogen and GPER levels in ADHD. Our preliminary findings suggest a relationship between serum GPER levels and ADHD, and this should be further investigated.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sahin</LastName><ForeName>Nilfer</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Child and Adolescent Psychiatry, School of Medicine, Mugla Sitki Kocman University, Mugla, Turkey. nilfersahin@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Altun</LastName><ForeName>Hatice</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Kurutaş</LastName><ForeName>Ergül Belge</ForeName><Initials>EB</Initials></Author><Author ValidYN="Y"><LastName>Fındıklı</LastName><ForeName>Ebru</ForeName><Initials>E</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>05</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>Bosnia and Herzegovina</Country><MedlineTA>Bosn J Basic Med Sci</MedlineTA><NlmUniqueID>101200947</NlmUniqueID><ISSNLinking>1512-8601</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004967">Estrogens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C109584">GPER1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011960">Receptors, Estrogen</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D043562">Receptors, G-Protein-Coupled</NameOfSubstance></Chemical><Chemical><RegistryNumber>4TI98Z838E</RegistryNumber><NameOfSubstance UI="D004958">Estradiol</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001289" MajorTopicYN="N">Attention Deficit Disorder with Hyperactivity</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004797" MajorTopicYN="N">Enzyme-Linked Immunosorbent Assay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004958" MajorTopicYN="N">Estradiol</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004967" MajorTopicYN="N">Estrogens</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011960" MajorTopicYN="N">Receptors, Estrogen</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D043562" MajorTopicYN="N">Receptors, G-Protein-Coupled</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012044" MajorTopicYN="N">Regression Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>01</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>02</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>4</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>11</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>4</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29659348</ArticleId><ArticleId IdType="doi">10.17305/bjbms.2018.2942</ArticleId><ArticleId IdType="pmc">PMC5988531</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Neuropsychobiology. 2006;53(4):169-75</Citation><ArticleIdList><ArticleId IdType="pubmed">16763376</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatr Clin North Am. 2010 Jun;33(2):357-73</Citation><ArticleIdList><ArticleId IdType="pubmed">20385342</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Acad Child Adolesc Psychiatry. 1994 Oct;33(8):1174-84</Citation><ArticleIdList><ArticleId IdType="pubmed">7982868</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Autism. 2014 Sep 09;5(1):46</Citation><ArticleIdList><ArticleId IdType="pubmed">25221668</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Endocrinol. 2011 Aug 16;7(12):715-26</Citation><ArticleIdList><ArticleId IdType="pubmed">21844907</ArticleId></ArticleIdList></Reference><Reference><Citation>Steroids. 2014 Mar;81:49-56</Citation><ArticleIdList><ArticleId IdType="pubmed">24240011</ArticleId></ArticleIdList></Reference><Reference><Citation>Horm Behav. 2009 Apr;55(4):465-79</Citation><ArticleIdList><ArticleId IdType="pubmed">19265696</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pharmacol Exp Ther. 2017 Jan;360(1):48-58</Citation><ArticleIdList><ArticleId IdType="pubmed">27789681</ArticleId></ArticleIdList></Reference><Reference><Citation>J Abnorm Child Psychol. 1978 Jun;6(2):221-36</Citation><ArticleIdList><ArticleId IdType="pubmed">670589</ArticleId></ArticleIdList></Reference><Reference><Citation>Steroids. 2012 Aug;77(10):935-42</Citation><ArticleIdList><ArticleId IdType="pubmed">22521564</ArticleId></ArticleIdList></Reference><Reference><Citation>World J Biol Chem. 2010 May 26;1(5):133-43</Citation><ArticleIdList><ArticleId IdType="pubmed">21540998</ArticleId></ArticleIdList></Reference><Reference><Citation>CNS Drugs. 2012 Jul 1;26(7):549-57</Citation><ArticleIdList><ArticleId IdType="pubmed">22626057</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2005 Mar 11;307(5715):1625-30</Citation><ArticleIdList><ArticleId IdType="pubmed">15705806</ArticleId></ArticleIdList></Reference><Reference><Citation>Horm Behav. 2010 Aug;58(3):415-26</Citation><ArticleIdList><ArticleId IdType="pubmed">20553724</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuropharmacology. 2017 Feb;113(Pt B):652-660</Citation><ArticleIdList><ArticleId IdType="pubmed">27392633</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Neuroendocrinol. 2014 Aug;35(3):331-46</Citation><ArticleIdList><ArticleId IdType="pubmed">24680800</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2001 Jul;158(7):1134-9</Citation><ArticleIdList><ArticleId IdType="pubmed">11431236</ArticleId></ArticleIdList></Reference><Reference><Citation>J Child Adolesc Psychopharmacol. 2015 Aug;25(6):501-8</Citation><ArticleIdList><ArticleId IdType="pubmed">26262904</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Womens Health. 2010 Aug 09;2:153-66</Citation><ArticleIdList><ArticleId IdType="pubmed">21072308</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Endocrinol. 2010 Nov;163(5):801-10</Citation><ArticleIdList><ArticleId IdType="pubmed">20807778</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroscientist. 2014 Oct;20(5):534-45</Citation><ArticleIdList><ArticleId IdType="pubmed">24510074</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2005 Jun 1;57(11):1336-46</Citation><ArticleIdList><ArticleId IdType="pubmed">15950006</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain Behav. 2014 Jan;4(1):51-9</Citation><ArticleIdList><ArticleId IdType="pubmed">24653954</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Cell Endocrinol. 2009 Sep 24;308(1-2):9-16</Citation><ArticleIdList><ArticleId IdType="pubmed">19549587</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Neuroendocrinol. 2009 Jul;30(2):v-ix</Citation><ArticleIdList><ArticleId IdType="pubmed">19393683</ArticleId></ArticleIdList></Reference><Reference><Citation>J Chem Neuroanat. 2016 Nov;77:60-67</Citation><ArticleIdList><ArticleId IdType="pubmed">27211874</ArticleId></ArticleIdList></Reference><Reference><Citation>Autism Res. 2009 Jun;2(3):157-77</Citation><ArticleIdList><ArticleId IdType="pubmed">19598235</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Acad Child Adolesc Psychiatry. 1997 Jul;36(7):980-8</Citation><ArticleIdList><ArticleId IdType="pubmed">9204677</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychoneuroendocrinology. 2015 Aug;58:51-66</Citation><ArticleIdList><ArticleId IdType="pubmed">25957002</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatry Res. 2016 Oct 30;244:312-6</Citation><ArticleIdList><ArticleId IdType="pubmed">27512921</ArticleId></ArticleIdList></Reference><Reference><Citation>World Neurosurg. 2015 Dec;84(6):1903-6</Citation><ArticleIdList><ArticleId IdType="pubmed">26325209</ArticleId></ArticleIdList></Reference><Reference><Citation>Prostaglandins Other Lipid Mediat. 2009 Sep;89(3-4):89-97</Citation><ArticleIdList><ArticleId IdType="pubmed">19442754</ArticleId></ArticleIdList></Reference><Reference><Citation>J Atten Disord. 2012 Apr;16(3):190-8</Citation><ArticleIdList><ArticleId IdType="pubmed">22290696</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatry Res. 2017 Nov;257:67-71</Citation><ArticleIdList><ArticleId IdType="pubmed">28734238</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Psychiatr Scand. 2001 Nov;104(5):323-31</Citation><ArticleIdList><ArticleId IdType="pubmed">11722312</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurosci Res. 2009 May 15;87(7):1610-9</Citation><ArticleIdList><ArticleId IdType="pubmed">19125412</ArticleId></ArticleIdList></Reference><Reference><Citation>Cytokine Growth Factor Rev. 2017 Apr;34:35-41</Citation><ArticleIdList><ArticleId IdType="pubmed">27919646</ArticleId></ArticleIdList></Reference><Reference><Citation>Turk Psikiyatri Derg. 2007 Spring;18(1):48-58</Citation><ArticleIdList><ArticleId IdType="pubmed">17364268</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Psychopharmacol Neurosci. 2017 Nov 30;15(4):337-342</Citation><ArticleIdList><ArticleId IdType="pubmed">29073745</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Cell Endocrinol. 2014 May 25;389(1-2):71-83</Citation><ArticleIdList><ArticleId IdType="pubmed">24530924</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Neuroendocrinol. 2012 Jan;33(1):85-104</Citation><ArticleIdList><ArticleId IdType="pubmed">22079780</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurosci. 2002 Apr 1;22(7):2650-9</Citation><ArticleIdList><ArticleId IdType="pubmed">11923430</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurogastroenterol Motil. 2017 Jul;29(7):null</Citation><ArticleIdList><ArticleId IdType="pubmed">28597596</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Res. 2015 Nov;168(3):603-13</Citation><ArticleIdList><ArticleId IdType="pubmed">25914107</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000931 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000931 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= MersV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:29659348
|texte= Evaluation of estrogen and G protein-coupled estrogen receptor 1 (GPER) levels in drug-naïve patients with attention deficit hyperactivity disorder (ADHD).
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:29659348" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a MersV1
| This area was generated with Dilib version V0.6.33. |  |